Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
iHSC012
- Development stage
- Preclinical
- Lead developer
- Cell Inspire Biotechnology
- Modality
- iPSCs → Pluripotent Stem Cells → Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
iHSC012 is a chimeric antigen receptor (CAR)-engineered cell therapy derived from induced pluripotent stem cells (iPSCs). Specifically, it consists of iPSC-derived hematopoietic stem cells (iHSCs) that have been modified to express a CAR targeting Trophoblast cell-surface antigen 2 (TROP2) and to secrete Interleukin-15 (IL-15). Developed by Cell Inspire Biotechnology, this therapy is designed to treat TROP2-positive solid tumors. The mechanism involves the CAR-iHSCs recognizing and binding to TROP2 on tumor cells, while the secreted IL-15 acts to enhance the expansion, persistence, and anti-tumor activity of the engineered cells within the immunosuppressive tumor microenvironment. It is currently in preclinical development.
02
Targets
IL-15R (Interleukin 15 receptor alpha/interleukin 15 complex)TACSTD2 (Tumor-associated calcium signal transducer 2)
Beyond the preview
Go deeper on iHSC012.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on iHSC012.